339 related articles for article (PubMed ID: 30738754)
1. Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.
Schiff DM; Grossman MR
Semin Fetal Neonatal Med; 2019 Apr; 24(2):115-120. PubMed ID: 30738754
[TBL] [Abstract][Full Text] [Related]
2. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
3. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
Velez ML; Jordan C; Jansson LM
Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcomes of neonatal opioid withdrawal syndrome in preterm infants: a retrospective cohort study in the current era.
Heyward A; Minich N; Hoffman AC; Hibbs AM; Zhao L; Crowley M
J Perinatol; 2023 Jul; 43(7):909-915. PubMed ID: 37188773
[TBL] [Abstract][Full Text] [Related]
5. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
Velez ML; Jordan CJ; Jansson LM
Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
[TBL] [Abstract][Full Text] [Related]
6. A Novel Approach to Assessing Infants With Neonatal Abstinence Syndrome.
Grossman MR; Lipshaw MJ; Osborn RR; Berkwitt AK
Hosp Pediatr; 2018 Jan; 8(1):1-6. PubMed ID: 29263121
[TBL] [Abstract][Full Text] [Related]
7. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
8. Correlating Scores but Contrasting Outcomes for Eat Sleep Console Versus Modified Finnegan.
Ryan K; Moyer A; Glait M; Yan K; Dasgupta M; Saudek K; Cabacungan E
Hosp Pediatr; 2021 Apr; 11(4):350-357. PubMed ID: 33653727
[TBL] [Abstract][Full Text] [Related]
9. A Quality Improvement Initiative to Increase Scoring Consistency and Accuracy of the Finnegan Tool: Challenges in Obtaining Reliable Assessments of Drug Withdrawal in Neonatal Abstinence Syndrome.
Timpson W; Killoran C; Maranda L; Picarillo A; Bloch-Salisbury E
Adv Neonatal Care; 2018 Feb; 18(1):70-78. PubMed ID: 29045256
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and analysis of the Modified Finnegan Scoring System for assessment of neonatal abstinence syndrome.
Baloch RQ; Pinto JM; Greenberg P; Kuo YH; Siu A
J Opioid Manag; 2020; 16(3):189-196. PubMed ID: 32421839
[TBL] [Abstract][Full Text] [Related]
11. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
Jones HE; Fielder A
Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure.
Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R
Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673
[TBL] [Abstract][Full Text] [Related]
13. Independent Impact of Eat, Sleep, Console Assessment on Neonatal Opioid Withdrawal Syndrome.
Chyi LJ; Li S; Lee C; Walsh EM; Kuzniewicz MW
Clin Pediatr (Phila); 2023 Oct; ():99228231204448. PubMed ID: 37798943
[TBL] [Abstract][Full Text] [Related]
14. Improving the Assessment of Neonatal Abstinence Syndrome (NAS).
Chin Foo CA; Dansereau LM; Hawes K; Oliveira EL; Lester BM
Children (Basel); 2021 Aug; 8(8):. PubMed ID: 34438576
[TBL] [Abstract][Full Text] [Related]
15. Physiologic dysregulation in newborns with prenatal opioid exposure: Cardiac, respiratory and movement activity.
Bloch-Salisbury E; Rodriguez N; Bruch T; McKenna L; Goldschmidt L
Neurotoxicol Teratol; 2022; 92():107105. PubMed ID: 35636580
[TBL] [Abstract][Full Text] [Related]
16. Neonatal Abstinence Syndrome: Prevention, Recognition, Treatment, and Follow-up.
Schroeder M; White J
S D Med; 2021 Dec; 74(12):576-583. PubMed ID: 35015949
[TBL] [Abstract][Full Text] [Related]
17. The Possibility of Early Discharge for Newborns Being Monitored for Neonatal Abstinence Syndrome Based on Modified Finnegan Score Distributions.
Oji-Mmuo CN; Schaefer EW; Liao L; Kaiser JR; Sekhar DL
Clin Pediatr (Phila); 2019 Jun; 58(6):641-646. PubMed ID: 30813757
[TBL] [Abstract][Full Text] [Related]
18. Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome.
Devlin LA; Breeze JL; Terrin N; Gomez Pomar E; Bada H; Finnegan LP; O'Grady KE; Jones HE; Lester B; Davis JM
JAMA Netw Open; 2020 Apr; 3(4):e202275. PubMed ID: 32267513
[TBL] [Abstract][Full Text] [Related]
19. Opioid neonatal abstinence syndrome: controversies and implications for practice.
Wolff K; Perez-Montejano R
Curr Drug Abuse Rev; 2014; 7(1):44-58. PubMed ID: 25323126
[TBL] [Abstract][Full Text] [Related]
20. The genetics and epigenetics of Neonatal Abstinence Syndrome.
Wachman EM; Farrer LA
Semin Fetal Neonatal Med; 2019 Apr; 24(2):105-110. PubMed ID: 30709700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
